Skip to main content

The Future of Digital Diabetes Care Is Here

Omada + Abbott have partnered to help people with diabetes manage their condition more safely, easily, and conveniently, thanks to continuous glucose monitoring (CGM) technology.

Download PDF
Omada + Abbot

Personalized care.
Continuous monitoring.
Better outcomes.

Omada + Abbott have partnered to help people with diabetes manage their condition more safely, easily, and conveniently, thanks to continuous glucose monitoring (CGM) technology.

People with diabetes face everyday challenges that are now elevated during the COVID-19 pandemic.

Regular in-person visits to healthcare facilities have evolved from inconvenient to potentially risky. Diabetes is a chronic condition that puts patients at increased risk of serious COVID complications, hospitalizations and death.1

Yet missing routine care is also a problem—one likely to drive up the cost of diabetes complications in the long-term.2 Recently, more than 200 healthcare professionals from 47 countries ranked diabetes as the condition that will be most impacted by the reduction in healthcare resources due to COVID-19.3 The ability for people with diabetes to access care and effectively manage their conditions remotely is more important than ever. When Omada Health and Abbott partnered to launch an integrated solution that includes Abbott’s Freestyle Libre 14 day system, a wearable continuous glucose monitoring technology and the Omada for Diabetes Program in late 2019, we could not have imagined what would transpire over the next 12 months. But 2020 has demonstrated conclusively that—pandemic or not—people with diabetes need access to safe, proven care delivered when and where they need it. As the nation’s largest CDC-recognized provider of diabetes prevention programs, and an accredited Diabetes SelfManagement Education and Support provider, Omada Health is now also the first digital health company to integrate and deploy a proven personalized diabetes coaching platform with Abbott’s FreeStyle Libre 14 day system for all eligible individuals.

In order to help drive sustainable behavior change for people with diabetes, Omada’s team is dedicated to delivering a personalized empathetic care experience with the power of actionable insights provided by FreeStyle Libre technology. Human relationships are at the heart of effective care, even when it is delivered digitally:

84% of members still want a human involved in their care no matter how advanced technology becomes4.

Additionally, 62% want a human health coach for guidance and motivation inside their digital health programs.4

Despite this desire, many digital diabetes solutions favor a reactive, automated approach built on nudging bots or randomly responding coaches reserved purely for emergencies or the most engaged members.

The Omada and Abbott partnership leverages the power of human connection alongside the stateof-the-art in diabetes monitoring technology. In a time of unique needs and social isolation, trusted longterm relationships and the agency with self-care that follows is more important than ever. Our solution pairs members with Omada’s dedicated Certified Diabetes Care and Education Specialists (CDCES) and health coaches who deliver personalized, proactive, real-time coaching and regularly review glucose data produced by the FreeStyle Libre 14 day Glucose Monitoring System. Let’s take a look at the two major components of our solution.

The easier way to manage diabetes.

See how CGM is changing the game.

Even during Covid-19, CGM technology helps your employees with diabetes monitor their A1C anytime, anywhere, all on their schedule. As the demand for better digital care grows, Omada + Abbott are reshaping the future of diabetes care.